在威尔逊病的功能性发作病例
Lucas D'Andrea1, Raphael Mosqueira1, Alcenor C Miranda Filho1
1Department of Neuropsychiatry, Institute of Psychiatry, Hospital das Clínicas, Faculty of Medicine, University of São Paulo, São Paulo, Brazil.
Epilepsy & behavior reports
|May 7, 2025
概括
威尔逊病 (WD) 是一种铜代谢障碍,可以引起神经和精神症状. 这一案例表明,功能性发作在WD患者中被误诊为,突出了诊断的复杂性.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 精神病学是一个精神病学.
背景情况:
- 威尔逊病 (WD) 是一种罕见的铜代谢遗传性疾病,导致肝脏和大脑等器官中有毒铜的积累.
- 神经心理症状在WD中很常见,使诊断和管理复杂化.
- 功能性 (FS) 的特征是类似于的发作,但没有异常的大脑电活动.
研究的目的:
- 为了呈现一个具有功能性发作的威尔逊病例,被误诊为.
- 突出WD中神经精神疾病表现的诊断复杂性.
- 强调区分功能性发作与在WD患者中的重要性.
主要方法:
- 一个22岁的女性患有威尔逊病的病例报告.
- 详细审查神经和精神症状,包括功能性发作.
- 对诊断过程和治疗结果的分析.
主要成果:
- 这位患者出现了神经症状和功能性发作,最初被误诊为两年来WD的次要发作.
- 患者病史显示了童年创伤和人际关系困难,有助于FS发展的心理因素.
- 这一案例强调了在WD中区分FS和的困难.
结论:
- 威尔逊病由于其多种神经精神疾病表现而带来了重大诊断挑战.
- 区分功能性发作和发作对于WD的适当管理至关重要.
- 多学科的护理和全面的评估对于优化WD和功能性发作患者的结果至关重要.
相关概念视频
Seizures: Classification
284
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
284
Antiepileptic Drugs: Potassium Channel Activators
126
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
126
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
187
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
187
Arteries of the Lower Limbs
166
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
166
Antiepileptic Drugs: Sodium Channel Blockers
262
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
262
Antiepileptic Drugs: GABAergic Pathway Potentiators
260
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
260


